XON News and Press, Intrexon Corporation From 01/06/20

GERMANTOWN, Md. , Jan. 6, 2020 /PRNewswire/ -- Precigen, Inc., a biopharmaceutical company specializing in the development of innovative gene and cellular therapies to improve the lives of patients, today announced that the US Food and Drug Administration (FDA) has granted orphan drug des...

Darling Ingredients ( DAR -1% ) announces that it acquired the 50% joint venture interest of EnviroFlight owned by Intrexon Corporation (NASDAQ: XON ). More news on: Darling Ingredients Inc., Intrexon Corporation, Consumer stocks news, Merger & acquisition news, Read more ...

IRVING, Texas , Jan. 2, 2020 /PRNewswire/ --   Darling Ingredients Inc.  (NYSE: DAR), today announced that it  has acquired the 50% joint venture interest of EnviroFlight, LLC owned by Intrexon Corporation (NASDAQ: XON), thereby increasing its ownership interest in En...

Reflecting its refocus on healthcare, Intrexon (NASDAQ: XON ) changes its name to Precigen, one of its subsidiaries. Shares will trade under the new symbol "PGEN." More news on: Intrexon Corporation, Healthcare stocks news, Stocks on the move, Read more ...

GERMANTOWN, Md. , Jan. 2, 2020 /PRNewswire/ -- Intrexon Corporation (NASDAQ: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, announced today that it will refocus the company on healthcare, change its name to Preci...

GERMANTOWN, Md. , Nov. 18, 2019 /PRNewswire/ --  Triple-Gene LLC , a clinical stage cardiovascular gene therapy company and majority owned subsidiary of Intrexon Corporation (NASDAQ: XON), yesterday presented preliminary data from the Phase I trial (clinical trial identifier: NCT034...

Intrexon Corp (XON) Precigen Inc Business and Pipeline Update Conference Call November 12, 2019 11:00 AM ET Company Participants Steven Harasym - VP, IR Dr. Helen Sabzevari - President, Precigen RJ Kirk - Chairman & CEO Conference Call Participants Jason Butler - JMP Se...

Intrexon ( XON ) Q3 results : Revenues: $23M (-29.0%). More news on: Intrexon Corporation, Healthcare stocks news, Earnings news and commentary, Read more ...

Intrexon (NASDAQ: XON ): Q3 GAAP EPS of -$0.35 misses by $0.13 . More news on: Intrexon Corporation, Earnings news and commentary, Healthcare stocks news, Read more ...

GERMANTOWN, Md. , Nov. 12, 2019 /PRNewswire/ --  Intrexon Corporation  (NASDAQ: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today announced its third quarter financial results for 2019. Re...